PaxMedica logo.jpg
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
April 11, 2024 16:30 ET | PaxMedica, Inc.
TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
Kainomyx logo.jpg
Kainomyx Announces New Funding to Advance Programs Focused on Malaria and Other Parasitic Diseases
October 26, 2021 15:41 ET | Kainomyx Inc.
PALO ALTO, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Kainomyx, Inc., founded in September 2019 and financed with $7.5M in May 2020, announced a new round of funding of $7.97M to advance its programs...
NOVARTIS logo.jpg
Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease
February 17, 2021 01:15 ET | Novartis International AG
Project brings together Novartis drug discovery and gene therapy expertise and funding support from the Gates Foundation  Agreement aims to address disparity in access to treatments and to prioritize...
Tropical Diseases: Prevention, Care and Cure
July 10, 2017 05:00 ET | BCC Research
Wellesley, Mass., July 10, 2017 (GLOBE NEWSWIRE) -- A new BCC Research report examines a growing need for treatment of prevention of tropical diseases and the impact on medical research that is...